Luděk Sojka graduated in Molecular and Cellular Biology at the Faculty of Science, Charles University Prague and gained his PhD in 2011. His professional career extends from the Czech Academy of Sciences at the Institute of Molecular Genetics and the Institute of Microbiology, where he studied the molecular mechanisms of protein synthesis and regulation of transcription. Since 2011, he has continued to study the molecular mechanisms of human cancer diseases at the Department of Immunology, 2nd Medical Faculty at Charles University in Prague.
As a Chief Technology Officer of SOTIO, he is responsible for the Department of Technical Operations in both SOTIO GMP facilities in Prague, Czech Republic and in Beijing, China including manufacturing of cell therapy products, quality control, logistics and process development along with leadership of technology transfers. Luděk joined SOTIO in 2011.